Extracorporeal Shock Wave Lithotripsy

Extracorporeal shock wave lithotripsy, commonly known as ESWL, is a non-invasive procedure that uses focused shock waves generated outside the body to break kidney or ureteric stones into small fragments that can then pass naturally through the urine. It is generally the first-choice treatment for moderate-sized stones because it avoids the need for any incision or internal instrumentation. Imaging is used throughout the session to precisely target the stone with the shock waves, minimizing exposure of surrounding tissue. Because success depends on the fragments being able to pass, ESWL works best for stones under about two centimetres and in favourable locations within the urinary tract.

Extracorporeal Shock Wave Lithotripsy is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Urology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is Same day, 45-60 minutes. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes The patient usually goes home the same day. Increased fluid intake is recommended to help pass stone fragments over the following one to two weeks, follow-up imaging confirms complete stone clearance, and repeat sessions are occasionally needed for larger stones.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Extracorporeal Shock Wave Lithotripsy has a documented success rate of 70-90% depending on stone size and location at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.